Glaukos Corporation vs Johnson & Johnson
GKOS vs JNJ — side-by-side comparison from reported financials. GKOS leads 2, JNJ leads 5 of 7 comparable metrics.
Glaukos Corporation
GKOS · Healthcare
$165.69+2.73%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | GKOS | JNJ |
|---|---|---|
| Price | $165.69 | $261.79 |
| Market cap | $9.77B | $631B |
| Revenue (TTM) | $613M | $97.9B |
| Revenue growth | +21.5% | +5.6% |
| Net margin | -30.7% | 21.5% |
| Free cash flow | -$12.2M | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | +90.4% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | — | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -27% | 26% |
| Altman Z-score | 23.88 | — |
| CV checks passed | 4 of 9 | 10 of 9 |
| Employees | 1,094 | 140,800 |
Full résumé-style profiles: GKOS CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.